DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Moustapha A, Naso A, Nahlawi M.
Prospective study of hyperhomocysteine as an adverse cardiovascular risk factor in end-stage renal disease
Circulation 1998; 97: 138-141
We do not assume any responsibility for the contents of the web pages of other providers.